Deutsche Krebshilfe
Krebs-Therapiestudien
Rolling deadline — applications accepted at any time
Last verified:
Deutsche Krebshilfe's Krebs-Therapiestudien programme funds non-commercial, investigator-initiated cancer therapy trials (IITs) in Germany on a rolling basis. Researchers submit a short-form Part I application; successful proposals are invited to submit a full Part II application. All proposals must be submitted in German and include a patient recruitment plan and sponsor declaration.
Details
| Funder | Deutsche Krebshilfe |
| Application | 2-stage: short application (Teil I) → full application (Teil II, by invitation only) |
| Frequency | Continuous |
| Eligible countries | DE |
Eligibility & scope
Funds non-commercial, investigator-initiated cancer therapy trials (Investigator Initiated Trials). Applicants submit a short-form Part I application; Part II is submitted only upon invitation from Deutsche Krebshilfe. Requires patient recruitment plan and sponsor declaration. Proposals must be submitted in German.
Who Should Apply
- •Researchers designing non-commercial, investigator-initiated cancer therapy trials
- •Applicants based at German institutions with capacity to recruit patients
- •Clinical researchers with access to patient populations and trial infrastructure
- •Teams prepared to submit applications in German and provide sponsor declarations
Key Dates
- •Rolling deadline, applications accepted at any time
- •Two-stage: Part I short application, then Part II full application by invitation only
Tips for Applicants
- ✓The Part I short application is a competitive filter, clarity and feasibility of the patient recruitment plan are decisive.
- ✓Sponsor declaration must be in place before submission; confirm institutional support early to avoid delays in Part II.
Frequently Asked Questions
What type of research does Deutsche Krebshilfe fund under Krebs-Therapiestudien?
Non-commercial, investigator-initiated cancer therapy trials (IITs) designed and led by researchers, not pharmaceutical industry-sponsored studies.
How does the application process work for Krebs-Therapiestudien?
Applicants submit a short Part I application; Deutsche Krebshilfe invites successful proposals to submit a full Part II application.
Can I submit a Krebs-Therapiestudien application any time?
Yes, the programme has a rolling deadline and accepts applications at any time.
Do I need a sponsor declaration to apply?
Yes, a sponsor declaration is a mandatory requirement for Krebs-Therapiestudien applications.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
More from Deutsche Krebshilfe
Mildred-Scheel-Postdoktorandenprogramm
Krebs-Prävention und -Früherkennung – Normalverfahren/Einzelförderung
Max-Eder-Nachwuchsgruppenprogramm
Mildred-Scheel-Professur
Klinische Forschung & kliniknahe Grundlagenforschung
Browse Related
Could Krebs-Therapiestudien be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →